NATURASON
DEAD

Serial Number

76122111

Owner

EPIGENESIS Pharmaceuticals, Inc.

Attorney

VIVIANA AMZEL

Filing Date

Aug 23, 2000

Add to watchlist:

No watchlists yet
View on USPTO

NATURASON Trademark

Serial Number: 76122111

NATURASON is a trademark filed by EPIGENESIS Pharmaceuticals, Inc. on August 23, 2000. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

EPIGENESIS Pharmaceuticals, Inc. (26 trademarks)

2055 East Park
Cranbury, NJ 08512

Entity Type: 03

Trademark Details

Filing Date

August 23, 2000

Registration Date

Not Registered

Published for Opposition

October 15, 2002

Goods & Services

Pharmaceutical preparations, namely, steroid hormone compound(s), including dehydroepiandrosterone derivatives and salts, for medical use, in the treatment of human and non-human animal respiratory, central nervous system, immune, endocrine, neoplastic and cardiovascular conditions, including bronchoconstriction, anxiety, Pre Menstrual Syndrome, Menopause symptoms, anxiety, lack of sleep, aggressive or ostensibly socially inappropriate behavior, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, pharmaceutical preparations for testing, preventing and therapeutically treating immune, central nervous system, endocrine, neoplastic, cardiovascular, respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, associated with the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg cancers which metastasized to the lung(s), breast and prostate included

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Sep 24, 2003 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2003 NOAM
PUBLISHED FOR OPPOSITION
Oct 15, 2002 PUBO
NOTICE OF PUBLICATION
Sep 25, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2002 CNSA
ASSIGNED TO EXAMINER
Jul 5, 2002 DOCK
Sec. 1(B) CLAIM ADDED
Jun 19, 2002 1.BA
SEC. 1(A) CLAIM DELETED
Jun 19, 2002 1.AD
EXAMINERS AMENDMENT MAILED
Jun 12, 2002 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2002 CRFA
FINAL REFUSAL MAILED
Nov 7, 2001 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2001 CRFA
NON-FINAL ACTION MAILED
Feb 7, 2001 CNRT
ASSIGNED TO EXAMINER
Jan 24, 2001 DOCK
ASSIGNED TO EXAMINER
Jan 23, 2001 DOCK